Trials / Completed
CompletedNCT05557149
Virtual Reality Exposure and Respiratory Relaxation-Based Coping With Cocaine Craving in Cocaine Users
Development and Evaluation of a Virtual Reality Application for Eliciting Craving and Its Physiological Arousal in Cocaine Users
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Laboratoire de Psychologie des Cognitions · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Our study main objective is to test whether virtual reality exposure could elicit cocaine craving and its physiological arousal in cocaine users. Investigators aim to compare self-reported cocaine craving, self-efficacy to cope with craving and emotional states levels in 11 voluntary and adults cocaine users in 3 consecutive 10-mins conditions: Neutral VR (virtual reality exposure to neutral stimuli), Cocaine VR (virtual reality exposure to cocaine use-related stimuli) and Relaxation (respiratory relaxation).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Virtual Reality Exposure to Neutral Cues | Virtual reality exposure to neutral stimuli (360 degrees visual and audio immersion with Oculus Quest 2 virtual reality headset). Participants stay sitted on chair and can tilt, rotate and move forward and backward upper body members. No interaction with the investigator during the virtual reality immersion. |
| BEHAVIORAL | Respiratory Relaxation | Respiratory relaxation practise. No interaction with the investigator during the relaxation practise. |
| DEVICE | Virtual Reality Exposure to Cocaine-Related Cues | Virtual reality exposure to cocaine-related stimuli (360 degrees visual and audio immersion with Oculus Quest 2 virtual reality headset). Participants stay sitted on chair and can tilt, rotate and move forward and backward upper body members. No interaction with the investigator during the virtual reality immersion. |
Timeline
- Start date
- 2021-03-31
- Primary completion
- 2021-07-29
- Completion
- 2021-07-29
- First posted
- 2022-09-27
- Last updated
- 2022-09-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05557149. Inclusion in this directory is not an endorsement.